BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Samsrita Labs Ltd. Share Price

NSE
BSE

BSE : 539267

Sector : Trading

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 0.0 0.0
Expenses N/A N/A
PBT -0.87 -2.6
Operating profit 0.0 0.0
Net profit -0.87 -2.6

Shareholding Pattern

Promoters (% Holding)

25.44%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

74.56%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Samsrita Labs Ltd.

Founded 1996

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Adani Enterprises Ltd. 3,95,441.46 3,026.50 1,753.00 - 1,753.00
Premier Energies Ltd. 49,004.07 1,079.50 660.00 - 660.00
Aditya Infotech Ltd. 42,886.38 3,639.05 0.00 - 0.00
Aegis Logistics Ltd. 35,394.84 1,006.95 576.10 - 576.10
Redington Ltd. 21,960.04 281.00 191.31 - 191.31
Honasa Consumer Ltd. 13,616.40 417.65 248.40 - 248.40
Lloyds Enterprises Ltd. 11,784.98 77.20 40.69 - 40.69
MMTC Ltd. 11,184.00 74.56 50.10 - 50.10
Cello World Ltd. 8,631.08 389.40 365.00 - 365.00
SG Mart Ltd. 7,539.43 597.20 313.10 - 313.10
no-content No Records Found

Latest News

Jun
20
2026
EQUITY Posted on Jun 20th 2026

Anik Industries informs about updates

Anik Industries has informed that this is with reference to SEBI Master Circular No. SEBI/HO/CFD/ PoD2/CIR/P/2023/120 dated 11th July, 2023 and BSE email dated Thursday, 18th June, 2026, in attention to the earlier communication dated Friday, 29th May, 2026, wherein the company informed the Exchange about the health issues of the Chief Financial Officer (CFO) leading to the Cancellation of the Board Meeting scheduled on Saturday, 30th May, 2026. The company reiterated that the primary and sole reason for the delay in the finalization and submission of the financial results continues to the sudden and unforeseen health issues of its CFO.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
EQUITY Posted on Jun 20th 2026

Centuple Global informs about EGM

Centuple Global has informed that it enclosed the following with respect to 01/2026-27 Extra-Ordinary General Meeting of Centuple Global (Formerly known as Checkpoint Treads) held on Thursday, June 18, 2026 at 09:00 AM through Video Conferencing (VC)/Other AudioVisual Means (OVAM)), without the physical presence of the Members at a common venue. All the resolutions have been passed with requisite majority by way of remote e-voting. Scrutinizer Report pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules, 2014. The same will be made available on the Company’s website at http://www.rubramed.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
EQUITY Posted on Jun 20th 2026

Adishakti Loha and Ispat informs about SAST disclosure

Adishakti Loha and Ispat has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pawan Kumar Mittal.
Adishakti Loha and Ispat informs about SAST The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
EQUITY Posted on Jun 20th 2026

Centuple Global submits EGM

Centuple Global has submitted the following with respect to 01st Extra- Ordinary General Meeting of the company, held on Thursday, June 18, 2026 at 09:00 am (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), without the physical presence of the Members at a common venue. All the resolutions have been passed with requisite majority by way of remote e-voting. 1. Voting Results pursuant to Regulation 44 (3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The same will be made available on the Company’s website at http://www.rubramed.com/.

The above information is a part of company’s filings submitted to BSE.

Read More
Jun
19
2026
EQUITY Posted on Jun 19th 2026

Welcure Drugs & Pharmaceuticals informs about resignation CS cum CO

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations, 2015’), and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023, Welcure Drugs & Pharmaceuticals has informed that Palak Jain have tendered his resignation as a Company Secretary (CS), Compliance Officer (CO) and key managerial personnel of the Company with effect from close of business hours of June 19, 2026. The resignation letter received from Palak Jain is also enclosed. The Board of Directors of the Company has noted the same and placed on record its sincere appreciation for the contribution made by Palak Jain during his tenure as a Company Secretary, Compliance Officer and key managerial personnel with the Company. The relevant details as required under Regulation 30 read with Schedule III - Para A of Part A of the SEBI Listing Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated 13th July 2023, are given in Annexure A. 
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Samsrita Labs Ltd. ?

The current share price of Samsrita Labs Ltd. is ₹12.71 as of 2026-06-19.

The market capitalisation of Samsrita Labs Ltd. is ₹28.91 as of 2026-06-19.

The 1-year return of Samsrita Labs Ltd. is -9.28% as of 2026-06-19.

The P/E ratio of Samsrita Labs Ltd. is 0.00 as of 2026-06-20.

The 52-week high and low of Samsrita Labs Ltd. are ₹26.04 and ₹12.70, respectively, as of 2026-06-19.

The dividend yield of Samsrita Labs Ltd. is 0.0% as of2026-06-19.

You can buy Samsrita Labs Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Samsrita Labs Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore